Dr. Avinash Ramani's Profile
Master of Science (M.Sc.) in Biotechnology and Bioinformatics, Ph.D ( Bioinformatics)
Dr. Avinash Ramani earned his BTech and Master's in Bioinformatics from Anna University and conducted significant research at IIT Madras. His innovations in cfDNA-based diagnostics have led to a US Patent, multiple government grants, and advancements in early cancer detection and non-invasive view more..
Written / Edited / Medically Reviewed
Circulating Cell-Free DNA Is Enabling Early Lung Cancer Diagnosis
Circulating cell-free DNA (cfDNA) analysis offers a non-invasive way to identify lung cancer, even at early stages, through DNA fragments in the bloodstream.
Circulating Cell-Free DNA: Key to Non-Invasive Diagnostics and Personalized Medicine
What is circulating cell-free DNA, and how can it change healthcare? Discover how cfDNA offers non-invasive insights for cancer, prenatal care, and organ transplants.
Liquid Biopsy - A Potential Tool to Prevent Kidney Transplant Rejections
Liquid biopsy using dd-cfDNA offers a non-invasive, accurate method for early kidney transplant rejection detection.
Plasma-Derived Cell-free DNA: A Promising Biomarker for Urothelial Carcinoma
Plasma-derived cell-free DNA and circulating tumor DNA are promising biomarkers for early detection of urothelial carcinoma.
Cell-Free DNA (cfDNA) Application in Cancer Detection
cfDNA offers a non-invasive approach for early cancer detection, monitoring treatment response, and identifying relapses, aiding in improved patient outcomes.